Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Cerebral venous thrombosis treated with enoxaparin in an IUGR neonate with DIC
Child's Nervous System, 04/24/09
Bertini G et al. - Treatment with enoxaparin was started at the initial dose of 0.5 mg/kg subcutaneously every 12 h and then at 1.25 mg/kg per 12 h in order to obtain anti-factor Xa levels between 0.5 and 1.0 U/ml. After hospital discharge, enoxaparin was continued for 2 months with a lower dose (1.8 mg/kg/die). Treatment with enoxaparin was effective as demonstrated by a complete "restitutio ad integrum".
Related Articles
Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment
Neurosurgical Focus, 11/10/09
Relevance Score: 81%
Prevention of Deep Venous Thrombosis and Pulmonary Embolism in Patients With Acute Intracerebral Hemorrhage
The Neurologist, 11/13/09
Relevance Score: 80%
Cerebral venous sinus thrombosis associated with oral contraceptives: the case for neurosurgery
Neurosurgical Focus, 11/11/09
Relevance Score: 80%
From presentation to follow-up: diagnosis and treatment of cerebral venous thrombosis
Neurosurgical Focus, 11/11/09
Relevance Score: 80%
Cerebral Venous Thrombosis: Diagnostic Accuracy of Combined, Dynamic and Static, Contrast-Enhanced 4D MR Venography
American Journal of Neuroradiology, 11/13/09
Relevance Score: 79%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Accumulation of intravenously administered methamphetamine in stomach contents
Forensic Toxicology, 12/16/09
Phenylephrine but not Ephedrine Reduces Frontal Lobe Oxygenation Following Anesthesia-Induced Hypotension
Neurocritical Care , 12/16/09
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Expert Opinion on Investigational Drugs, 12/16/09
Today in HemeOnc Emergencies...keeping you current
Receive free subspecialty "5-minute updates" via email
The Effect of Intraventricular Administration of Nicardipine on Mean Cerebral Blood Flow Velocity Measured by Transcranial Doppler in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
Neurocritical Care , 12/16/09
Moderate Hypoglycemia is Associated With Vasospasm, Cerebral Infarction, and 3-Month Disability After Subarachnoid Hemorrhage
Neurocritical Care , 12/16/09
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Expert Opinion on Investigational Drugs, 12/16/09
Today in Neurology/Neurosurgery...keeping you current
Receive free subspecialty "5-minute updates" via email
The Effect of Intraventricular Administration of Nicardipine on Mean Cerebral Blood Flow Velocity Measured by Transcranial Doppler in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
Neurocritical Care , 12/16/09
Phenylephrine but not Ephedrine Reduces Frontal Lobe Oxygenation Following Anesthesia-Induced Hypotension
Neurocritical Care , 12/16/09
Moderate Hypoglycemia is Associated With Vasospasm, Cerebral Infarction, and 3-Month Disability After Subarachnoid Hemorrhage
Neurocritical Care , 12/16/09
Today in Pediatric Emergencies...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation
Pediatric Pulmonology, 12/16/09
Assessing the feasibility of distributing child poison safety messages through three existing parent information pathways
Injury Prevention, 12/15/09
Ventilation and oxygen: cumulative effects of oxygen on ventilation induced lung injury
Pediatric Research, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


